Relx: old publisher learns new tricks

The pandemic has been good for academic publisher Relx, helping it to weather a crisis that was harmful to its associated events business. Debates over vaccine efficacy have underlined the need for strong, peer-reviewed journals. Recent results recorded a rebound in underlying revenues of 7 per cent to £7.2bn in 2021.